Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes
Authors:
- Claudia S. CabreraCCClaudia S. Cabrera
- Alison S. LeeALAlison S. Lee
- Marita OlssonMOMarita Olsson
- Volker SchneckeVSVolker Schnecke
- Klara WestmanKWKlara Westman
- Marcus LindMLMarcus Lind
- Peter J. GreasleyPGPeter J. Greasley
- Stanko SkrticSSStanko Skrtic
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Kidney International Reports
- Vol. 5 (10) , 1651-1660
Abstract
No abstract availableKeywords
Funding Information
- Eli Lilly and Company
- Novo Nordisk
This publication has 27 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Cardiovascular Risk PredictionCirculation, 2010
- Change in Estimated GFR Associates with Coronary Heart Disease and MortalityJournal of the American Society of Nephrology, 2009
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Cardiorenal SyndromeJACC, 2008
- Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 DiabetesNew England Journal of Medicine, 2008
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspectiveKidney International, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairmentKidney International, 1999